News
May 13, 2025
AbTherx, Single Cell Technology, and Vaccinex Announce Collaboration to Tackle...
AbTherx and Single Cell Technology incorporate ActivMAb® Technology into Atlas™ Mouse and AbTheneum™ antibody discovery platforms Mountain View, Calif. – May 13, 2025... Read More »
May 12, 2025
AbTherx and Spice Biotechnologies Announce Multi-Program Antibody Discovery Collaboration
Immuno-oncology pioneer partners with AbTherx to build the next generation of immunotherapy drugs Mountain View, Calif. – May 12, 2025 – AbTherx, Inc., a biotechnolog... Read More »
April 23, 2025
AbTherx and Rondo Therapeutics Announce Multi-Program Antibody Discovery Collaboration
Partnership leverages AbTherx’s Atlas™ Binary Fixed Light Chain Mouse to accelerate Rondo’s pipeline of bispecific antibodies Mountain View, Calif. – April 23, 2025 –... Read More »
October 31, 2024
AbTherx and Gilead Expand Collaboration on Innovative Antibody Discovery Technologies
Expanded agreement includes development of additional transgenic mouse technologies and performance of additional therapeutic antibody research programs Foster City, ... Read More »
July 17, 2024
AbTherx Appoints Pallavi Tawde, PhD, as Head of Preclinical R&D...
Former Pfizer, BMS, and Denali scientific leader to lead expansion of antibody discovery, preclinical development, and early clinical capabilities Foster City, Calif.... Read More »
